No profile data available.
Solventum Corporation (SOLV) is a healthcare company in the additional healthcare consumables industry, based in Eagan, United States, with about 20,584 full-time employees.
It reported revenue of $8.33 billion for fiscal year 2025, up 0.9% from fiscal year 2024, and net income of $1.56 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $2.21 billion, up 2.2% from a year before. Its largest business segment, Medsurg, brought in 58% of segment revenue in fiscal year 2025; United States was the largest region with 56%. Its market capitalization was $14.86 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. V.
Solventum reported $8.33 billion in revenue for fiscal year 2025, up 0.9% from $8.25 billion in fiscal year 2024. In Q2 2026 revenue was $2.21 billion.
Medsurg, with $4.82 billion or 58% of segment revenue in fiscal year 2025. Next: Health Information Systems (16%) and Dental Solutions (16%).
United States: 56% of revenue by region in fiscal year 2025, followed by International (44%).
$14.86 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional healthcare consumables) include Omnicell, Inc. (OMCL), Tevano Systems Holdings Inc. (TEVNF).